Defunct Company
Total Trials
22
As Lead Sponsor
18
As Collaborator
4
Total Enrollment
9,224
NCT00063089
Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 30, 2002
Completion: Sep 30, 2004
NCT00066989
Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates
Phase: Phase 2
Start: Jul 31, 2003
Completion: Aug 31, 2004
NCT00071214
Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis
Phase: Phase 3
Start: Sep 30, 2003
Completion: Sep 30, 2005
NCT00211913
StaphVAX in Cardiovascular Surgery Patients
Start: Jun 30, 2004
Completion: Jan 31, 2006
NCT00218413
Safety and Effectiveness of NicVAX in Treating Nicotine Dependent Individuals
Start: Oct 31, 2004
Completion: Aug 31, 2006
NCT00211926
StaphVAX Immunogenicity in Orthopedic Implant Patients
Start: Dec 31, 2004
Completion: Oct 31, 2006
NCT00211939
CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients
Phase: Phase 4
Start: Jan 31, 2005
Completion: Mar 31, 2007
NCT00211900
Evaluation of Manufacturing Lot of StaphVAX
Start: Mar 31, 2005
Completion: Nov 30, 2005
NCT00211965
StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery
Start: Apr 30, 2005
NCT00211991
Evaluation of Consistency of StaphVAX Manufacturing Lots
Completion: Jul 31, 2005
NCT00211978
EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)
Start: May 31, 2005
NCT00130260
Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease
Start: Aug 31, 2005
Completion: Apr 30, 2006
NCT00318383
Efficacy of NicVAX in Smokers Who Want to Quit Smoking
Role: Collaborator
Start: May 31, 2006
Completion: Dec 31, 2007
NCT00598325
Antibody and Safety Study of 6 Doses of NicVAX in Smokers
Start: Jan 31, 2008
Completion: Oct 31, 2010
NCT00996034
Nicotine Vaccination and Nicotinic Receptor Occupancy
Start: Sep 30, 2009
Completion: Feb 28, 2011
NCT00836199
NicVAX/Placebo as an Aid for Smoking Cessation
Start: Oct 31, 2009
Completion: Jul 31, 2011
NCT00995033
Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)
Completion: Sep 30, 2012
NCT01011335
Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial
Start: Nov 30, 2009
Completion: Mar 31, 2011
NCT01102114
A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation
Start: Mar 31, 2010
Completion: Nov 30, 2011
NCT01178346
Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies
Start: Jul 31, 2010
NCT01304810
A Follow-up Study to Assess Long-term Immunogenicity and Safety of NicVAX/Placebo as an Aid to Smoking Cessation
Phase: N/A
Start: Jan 31, 2011
Completion: Aug 31, 2011
NCT01375933
A Comparability Study of the Phase 3 Lot and a Single Commercial Lot of NicVAX in Healthy Adult Smokers
Start: May 31, 2011
Completion: Oct 31, 2011